NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 80 filers reported holding NOVELION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 2.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 600 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 600 | -69.5% | 0.00% | – |
| Q1 2019 | $3,000 | +200.0% | 1,964 | +227.3% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | -84.6% | 600 | -83.5% | 0.00% | – |
| Q1 2018 | $13,000 | +8.3% | 3,645 | -5.9% | 0.00% | – |
| Q4 2017 | $12,000 | -77.8% | 3,873 | -50.0% | 0.00% | – |
| Q3 2017 | $54,000 | +315.4% | 7,740 | +451.3% | 0.00% | – |
| Q2 2017 | $13,000 | -88.2% | 1,404 | -86.4% | 0.00% | – |
| Q1 2017 | $110,000 | +243.8% | 10,292 | +167.2% | 0.00% | – |
| Q4 2016 | $32,000 | – | 3,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|